Lorlatinib beyond progression plus platinum/pemetrexed for ALK-positive non-small cell lung cancer patients: report of two cases.
- Resource Type
- Article
- Source
Journal of Chemotherapy (Taylor & Francis Ltd) . Oct2023, Vol. 35 Issue 6, p576-582. 7p.- Subject
- Language
- ISSN
- 1120-009X